Home ›
Trademark Categories ›
Pharmaceuticals ›
1999 ›
AC ›
ACCURATE 24
Trademark search for:
ACCURATE 24
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
1999-12-03 — Application filed
2000-04-27 — Assigned to examiner
2000-05-08 — Letter of suspension mailed
2001-12-11 — Approved for pub - principal register
2002-02-27 — Notice of publication
2002-03-19 — Published for opposition
2002-06-11 — Noa mailed - sou required from applicant
2002-11-19 — Sou teas extension received
2002-11-19 — Sou extension 1 filed
2002-11-19 — Sou extension 1 granted
2003-05-07 — Sou teas extension received
2003-05-07 — Sou extension 2 filed
2003-06-03 — Sou extension 2 granted
2003-11-12 — Sou teas extension received
2003-11-12 — Sou extension 3 filed
2003-11-22 — Sou extension 3 granted
2004-04-26 — Assigned to examiner
2004-05-05 — Sou teas extension received
2004-05-05 — Sou extension 4 filed
2004-05-11 — Case file in ticrs
2004-05-12 — Sou extension 4 granted
2004-11-08 — Sou teas extension received
2004-11-08 — Sou extension 5 filed
2004-11-16 — Sou extension 5 granted
2005-06-12 — Final status recorded
2005-09-27 — Application abandoned
2005-09-27 — Application abandoned
Owner Information
SmithKline Beecham Corporation
Philadelphia , PA
SmithKline Beecham Corporation
Philadelphia , PA
Correspondent
CHRISTOPHER A SIDOTI CORPORATE INTELLECTUAL PROP (TRADEMARK) SMITHKLINE BEECHAM CORPORATION 709 SWEDELAND RD - UW2221 KING OF PRUSSIA, PA 19406
Filing Details
Filing Date:
1999-12-03
Status Date:
2005-06-12
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.